Orthofix today announced plans to present new data supporting the use of its proprietary pulsed electromagnetic field (PEMF) stimulation. Lewisville, Texas-based Orthofix is evaluating PEMF stimulation to increase fusion rates as an adjunct to lumbar spine fusion surgery. Patients treated with the SpinalStim bone growth therapy demonstrated a high rate of successful fusion, according to […]
Orthofix
Orthofix taps former Stryker VP as new global orthopedics president
Orthofix announced today that it appointed Patrick Fisher to the post of president of its global orthopedics business. In the role, Fisher serves on the company’s executive leadership team, reporting to President and CEO Massimo Calafiore. He succeeds Kimberley Etling, who departed Orthofix in July through a mutual separation agreement. “Orthofix has a uniquely differentiated […]
Orthofix stock gets a boost from Q2 earnings beat, raised guidance
Orthofix shares ticked up today on second-quarter results that topped the consensus forecast on Wall Street. Shares of OFIX rose by nearly 14% to $16.62 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 1.1%. Lewisville, Texas-based Orthofix — one of […]
FDA clears Orthofix Fitbone transport and lengthening system
Orthofix (Nasdaq: OFIX) today announced it received FDA 510(k) clearance for the Fitbone Transport and Lengthening System and reported the first implant of the device. The Lewisville, Texas–based company designed Fitbone to treat large bone defects in the femur and tibia caused by trauma, infectious, or malignant conditions. “Patients with defects to the femur and tibia […]
Orthofix has a new board chair
Orthofix Medical (Nasdaq: OFIX) recently announced that Michael Finegan was appointed chair of its board of directors. Finegan was previously appointed to the Orthofix board in December 2023. He is CEO of Acera Surgical, which is developing and commercializing a portfolio of fully engineered synthetic materials for soft tissue repair and regenerative medicine. Before joining […]
Orthofix’s global orthopedics president is stepping down
Orthofix President of Global Orthopedics Kimberley Elting is stepping down from the company on July 5. According to a filing with the Securities and Exchange Commission today, Elting is departing as an executive and employee of Orthofix Medical (Nasdaq: OFIX) in a mutual separation agreement. She did not disclose her next move in medtech. Elting joined […]
Orthofix appoints Aviva McPherron as president of global operations and quality
Orthofix Medical (Nasdaq: OFIX) today announced that it has appointed Aviva McPherron as president of its global operations and quality. McPherron will oversee strategy for the company’s operations, manufacturing, regulatory, clinical and quality teams. Prior to joining Orthofix, McPherron served as senior VP of clinical services and integration at Globus Medical, where she was responsible […]
The 10 largest orthopedic device companies in the world
Our list of the largest orthopedic device companies has changed a lot since last year. A change in methodology means there is a new company at the top of this year’s MassDevice and Medical Design & Outsourcing ranking of the world’s largest orthopedic device companies. But mergers and spinoffs also added to the list two […]
Orthofix appoints Julie Dewey chief investor relations, communications officer
Orthofix today announced it appointed Julie Dewey as its new chief investor relations and communications officer. With the latest appointment news, Orthofix also announced that Max Reinhardt has officially begun his role as president of the company’s global spine business. Both Dewey and Reinhardt will serve on Orthofix’s executive leadership team. Dewey previously held corporate […]
Former DePuy Synthes Spine president takes same post at Orthofix
Orthofix announced today that it appointed Max Reinhardt as president of its Global Spine business. Reinhardt’s move, which includes serving on the company’s executive leadership team, goes into effect on June 10, 2024. His responsibilities include leading SeaSpine, the company’s global spine and biologics business created through a massive merger last year. It marks the […]
Orthofix wins FDA 510(k) clearance for Rodeo Telescopic Nail
Orthofix today announced it received FDA 510(k) clearance for its Rodeo Telescopic Nail. The Lewisville, Texas-based orthopedic company designed the Rodeo Telescopic Nail to surgically treat deformities or fractures in osteogenesis imperfecta (OI) patients. The nail implant stabilizes the patient’s limb while also elongating (or telescoping) to accommodate the natural growth of pediatric patients. […]
